28233508|t|Viral Vector Biosafety in Laboratory Animal Research
28233508|a|Viral vector research presents unique occupational health and safety challenges to institutions due to the rapid development ofboth in vivo and in vitro gene-editing technologies. Risks to human and animal health make it incumbent on institutions to appropriately evaluate viral vector usage in research on the basis of available information and governmental regulations and guidelines .Here we review the factors related to risk assessment regarding viral vector usage in animals and the relevant regulatory documents associated with this research, and we highlight the most commonly used viral vectors in research today. This review is particularly focused on the background, use in research and associated health and environmental risks related to adenoviral, adeno-associated viral, lentiviral, and herpesviral vectors.
28233508	0	12	Viral Vector	T121	C1520007
28233508	13	22	Biosafety	T170	C1443933
28233508	26	52	Laboratory Animal Research	T062	C0003048
28233508	53	65	Viral vector	T121	C1520007
28233508	66	74	research	T062	C0035168
28233508	75	83	presents	T078	C0449450
28233508	84	90	unique	T080	C1710548
28233508	91	110	occupational health	T091	C0079920
28233508	115	121	safety	T068	C0036043
28233508	122	132	challenges	T058	C0805586
28233508	136	148	institutions	T093	C2607850
28233508	160	165	rapid	T080	C0456962
28233508	166	177	development	T169	C1527148
28233508	185	192	in vivo	T082	C1515655
28233508	197	205	in vitro	T080	C1533691
28233508	206	231	gene-editing technologies	T063	C4277689
28233508	233	238	Risks	T078	C0035647
28233508	242	247	human	T016	C0086418
28233508	252	258	animal	T008	C0003062
28233508	259	265	health	T078	C0018684
28233508	274	283	incumbent	T080	C3898777
28233508	287	299	institutions	T093	C2607850
28233508	303	316	appropriately	T080	C1548787
28233508	317	325	evaluate	T058	C0220825
28233508	326	338	viral vector	T121	C1520007
28233508	339	344	usage	T169	C0457083
28233508	348	356	research	T062	C0035168
28233508	364	369	basis	T169	C1527178
28233508	373	382	available	T169	C0470187
28233508	383	394	information	T078	C1533716
28233508	399	423	governmental regulations	T064	C0034982
28233508	428	438	guidelines	T170	C0162791
28233508	448	454	review	T078	C1552617
28233508	459	466	factors	T169	C1521761
28233508	478	493	risk assessment	T058	C0086930
28233508	504	516	viral vector	T121	C1520007
28233508	517	522	usage	T169	C0457083
28233508	526	533	animals	T008	C0003062
28233508	542	550	relevant	T080	C2347946
28233508	551	571	regulatory documents	T170	C1301746
28233508	572	587	associated with	T080	C0332281
28233508	593	601	research	T062	C0035168
28233508	624	628	most	T081	C0205393
28233508	629	637	commonly	T081	C0205214
28233508	643	656	viral vectors	T121	C1520007
28233508	660	668	research	T062	C0035168
28233508	681	687	review	T078	C1552617
28233508	691	703	particularly	T080	C0205369
28233508	704	711	focused	T169	C1285542
28233508	719	729	background	T077	C1706907
28233508	738	746	research	T062	C0035168
28233508	751	761	associated	T080	C0332281
28233508	762	768	health	T078	C0018684
28233508	773	792	environmental risks	T080	C0686732
28233508	793	800	related	T080	C0439849
28233508	804	814	adenoviral	T005	C0001483
28233508	816	838	adeno-associated viral	T005	C1564874
28233508	840	850	lentiviral	T005	C0079679
28233508	856	867	herpesviral	T005	C0019369
28233508	868	875	vectors	T121	C1520007